Dated : 16th January, 2004

NPPA has revised the prices of bulk drugs Carbamezapine, Aspirin, Analgin, Doxycycline Hcl and Spironolactone. The prices in respect of bulk drugs Carbamezapine, Aspirin and Analgin have been revised after conducting the detailed cost price study of M/s Jubilant Organosys, (for Carbamazepine) M/s Alta Labs and M/s Andhra Sugars (for Aspirin) and M/s Vani Chemicals (for Analgin). The price of the bulk drug Doxycycline Hcl has been revised based on available information with NPPA. The price of bulk drug Spironolactone has been revised as M/s RPG Life Sciences has re-started the production of the drug in the country. The revised price is comparable with the import price of the drug. The import price had also been considered while fixing the prices of Spironolactone based formulations. The details of pre-revised and revised prices are given below:

The revised notified prices shall become effective within 15 days from the date of notification in the Official Gazette. All formulators utilizing these drugs in their scheduled formulations are advised to follow the provisions of DPCO, 1995.

Copy of Explanatory Note

For Copies of Notifications please click the following :

(Dr. P.V. Appaji)
Director (M&S)